Revenio Group Oyj — Director's Dealing 2022

May 11, 2022

REVENIO

Revenio Group Corporation: Managers' Transactions - Bill Östman

Revenio Group Corporation, Managers' transactions, May 11, 2022 at 3.00 p.m. (EEST)

Revenio Group Corporation: Managers' Transactions – Bill Östman

Person subject to the notification requirement

Name: Bill Östman
Position: Member of the Board/Deputy member
Issuer: Revenio Group Oyj
LEI: 743700127E0FWSXLKK04
Notification type: INITIAL NOTIFICATION
Reference number: 14605/6/6

Transaction date: 2022-05-11
Venue not applicable
Instrument type: SHARE
ISIN: F10009010912
Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE

Transaction details
(1): Volume: 428 Unit price: 0 N/A
Aggregated transactions
(1): Volume: 428 Volume weighted average price: 0 N/A

For further information, please contact
CFO Robin Pulkkinen, tel. +358 50 505 9932
robin.pulkkinen@revenio.fi
www.revenio.fi

Distribution
Nasdaq Helsinki Ltd
Main media
www.revenio.fi

Revenio Group in brief

Revenio is a leading company in the global market for ophthalmological devices and software solutions. Revenio's ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), fundus imaging devices, and perimeters as well as clinical software under the iCare brand. iCare is a trusted partner in ophthalmic diagnostics, offering

Revenio Group
Àyritie 22
FI-01510 Vantaa

---

REVENIO

physicians fast, easy-to-use, and reliable tools for the diagnosis of glaucoma, diabetic retinopathy, and macular degeneration (AMD). iCare software solutions provide eye care professionals with new innovative digital clinical tools that drive greater efficiency and enhance the quality of care.

In 2021, the Group's net sales totaled EUR 78.8 million, with an operating profit of EUR 22.1 million. Revenio Group Corporation is listed on Nasdaq Helsinki with the trading code REG1V.

Attachments

Revenio Group Corporation: Managers' Transactions – Bill Östman

Revenio Group | Äyritie 22 | FI-01510 Vantaa